As per Pfizer CEO Albert Bourla, a contract for COVID-19 vaccine supply has been made with the Indian government
On June 22, Pfizer CEO Albert Bourla said the company was in the final stages of signing an agreement with the Indian government to supply COVID-19 vaccines.
“We are discussing with India govt, we are in final stages of finalising the agreement,” Bourla said at the 15th annual BioPharma & Healthcare Summit, USA-India Chamber of Commerce (USAIC)
“We need to get approval of this vaccine in India. We are in a good way to get approval. Then we have to have a sign an agreement that will allow us to send doses,” Bourla said.
Pfizer will be able to produce 3 billion vaccines by 2021, and 4 billion by 2022, according to Bourla.
Pfizer’s COVID-19 vaccines will be distributed to LMIC countries at least twice a year in the coming years, with at least one billion doses being given out in 2018.
In a recent agreement, Pfizer and the U.S. government agreed that the US government would purchase 500 million doses of COVID-19 below the cost of production, and give them to LMICs free of charge.